Efficacy and Safety of Erenumab for Nonopioid Medication Overuse Headache in Chronic Migraine: A Phase 4, Randomized, Placebo-Controlled Trial

MLA

Tepper, Stewart J., et al. “Efficacy and Safety of Erenumab for Nonopioid Medication Overuse Headache in Chronic Migraine: A Phase 4, Randomized, Placebo-Controlled Trial.” JAMA Neurology, vol. 81, no. 11, Nov. 2024, pp. 1140–49. EBSCOhost, https://doi.org/10.1001/jamaneurol.2024.3043.

APA

Tepper, S. J., Dodick, D. W., Lanteri-Minet, M., Dolezil, D., Gil-Gouveia, R., Lucas, C., Piasecka-Stryczynska, K., Szabó, G., Mikol, D. D., Chehrenama, M., Chou, D. E., Yang, Y., & Paiva da Silva Lima, G. (2024). Efficacy and Safety of Erenumab for Nonopioid Medication Overuse Headache in Chronic Migraine: A Phase 4, Randomized, Placebo-Controlled Trial. JAMA Neurology, 81(11), 1140–1149. https://doi.org/10.1001/jamaneurol.2024.3043

Chicago

Tepper, Stewart J., David W. Dodick, Michel Lanteri-Minet, David Dolezil, Raquel Gil-Gouveia, Christian Lucas, Karolina Piasecka-Stryczynska, et al. 2024. “Efficacy and Safety of Erenumab for Nonopioid Medication Overuse Headache in Chronic Migraine: A Phase 4, Randomized, Placebo-Controlled Trial.” JAMA Neurology 81 (11): 1140–49. doi:10.1001/jamaneurol.2024.3043.